KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Treasury Shares (2016 - 2025)

Historic Treasury Shares for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • West Pharmaceutical Services' Treasury Shares rose 1155.75% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1155.75%. This contributed to the annual value of $1.1 billion for FY2024, which is 6579.36% up from last year.
  • West Pharmaceutical Services' Treasury Shares amounted to $3.4 million in Q3 2025, which was up 14117.14% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Treasury Shares ranged from a high of $3.5 million in Q1 2025 and a low of $753399.0 during Q3 2023
  • Moreover, its 5-year median value for Treasury Shares was $1.4 million (2023), whereas its average is $1.8 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Treasury Shares soared by 627.52% in 2023, and later soared by 12351.03% in 2024.
  • West Pharmaceutical Services' Treasury Shares (Quarter) stood at $229.5 million in 2021, then soared by 61.61% to $370.9 million in 2022, then soared by 71.91% to $637.6 million in 2023, then soared by 65.79% to $1.1 billion in 2024, then rose by 6.65% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.2 billion during Q1 2025.